Tumor Biomarker Test Market Report

Global and Region Tumor Biomarker Test Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：221
  • REPORT CODE：GMM981716
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Tumor Biomarker Test market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Tumor Biomarker Testmarket, defines the market attractiveness level of Tumor Biomarker Test market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Tumor Biomarker Test industry, describes the types of Tumor Biomarker Test market, the applications of major players and the market size, and deeply analyzes the current situation of the global Tumor Biomarker Test market and the development prospects and opportunities of Tumor Biomarker Test industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Tumor Biomarker Test market in Chapter 13.

    By Player:

    • Myriad Genetics Inc

    • Becton Dickinson and Co

    • Agilent Technologies

    • Abbott Laboratories, Inc

    • Cancer Genetics Inc

    • Foundation Medicine Inc

    • Luminex Corporation

    • Illumina Inc

    • AstraZeneca

    • LabCorp Of America Holdings

    • Biocept Inc

    • NanoString Technologies Inc

    • Danaher Corporation

    By Type:

    • Prostate Specific Antigen Tests

    • CTC Tests

    • Alpha-Fetoprotein (AFP) Tests

    • CA Test

    • HER2 Tests

    • BRCA Test

    • Anaplastic Lymphoma Kinase (ALK) Tests

    • EGFR Mutation Tests

    • KRAS Test

    • Others

    By End-User:

    • Lung Cancer

    • Breast Cancer

    • Colorectal

    • Prostate Cancer

    • Blood Cancer

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Tumor Biomarker Test Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Tumor Biomarker Test Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Tumor Biomarker Test Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Tumor Biomarker Test Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Tumor Biomarker Test Market Analysis and Outlook to 2022

    • 7.1 Global Tumor Biomarker Test Consumption (2017-2022)

    • 7.2 United States Tumor Biomarker Test Consumption (2017-2022)

    • 7.3 Europe Tumor Biomarker Test Consumption (2017-2022)

    • 7.4 China Tumor Biomarker Test Consumption (2017-2022)

    • 7.5 Japan Tumor Biomarker Test Consumption (2017-2022)

    • 7.6 India Tumor Biomarker Test Consumption (2017-2022)

    • 7.7 South Korea Tumor Biomarker Test Consumption (2017-2022)

    8 Region and Country-wise Tumor Biomarker Test Market Analysis and Outlook to 2028

    • 8.1 Global Tumor Biomarker Test Consumption Forecast (2022-2028)

    • 8.2 United States Tumor Biomarker Test Consumption Forecast (2022-2028)

    • 8.3 Europe Tumor Biomarker Test Consumption Forecast (2022-2028)

    • 8.4 China Tumor Biomarker Test Consumption Forecast (2022-2028)

    • 8.5 Japan Tumor Biomarker Test Consumption Forecast (2022-2028)

    • 8.6 India Tumor Biomarker Test Consumption Forecast (2022-2028)

    • 8.7 South Korea Tumor Biomarker Test Consumption Forecast (2022-2028)

    9 Global Tumor Biomarker Test Market Outlook by Types and Applications to 2022

    • 9.1 Global Tumor Biomarker Test Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Prostate Specific Antigen Tests Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global CTC Tests Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Alpha-Fetoprotein (AFP) Tests Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global CA Test Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global HER2 Tests Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global BRCA Test Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Anaplastic Lymphoma Kinase (ALK) Tests Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global EGFR Mutation Tests Consumption and Growth Rate (2017-2022)

      • 9.1.9 Global KRAS Test Consumption and Growth Rate (2017-2022)

      • 9.1.10 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Tumor Biomarker Test Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Lung Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Breast Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Colorectal Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Prostate Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Blood Cancer Consumption and Growth Rate (2017-2022)

    10 Global Tumor Biomarker Test Market Outlook by Types and Applications to 2028

    • 10.1 Global Tumor Biomarker Test Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Prostate Specific Antigen Tests Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global CTC Tests Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Alpha-Fetoprotein (AFP) Tests Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global CA Test Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global HER2 Tests Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global BRCA Test Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Anaplastic Lymphoma Kinase (ALK) Tests Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global EGFR Mutation Tests Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.9 Global KRAS Test Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.10 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Tumor Biomarker Test Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Colorectal Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)

    11 Global Tumor Biomarker Test Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Tumor Biomarker Test Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Tumor Biomarker Test Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Tumor Biomarker Test Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Tumor Biomarker Test Market Competitive Analysis

    • 14.1 Myriad Genetics Inc

      • 14.1.1 Myriad Genetics Inc Company Details

      • 14.1.2 Myriad Genetics Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Myriad Genetics Inc Tumor Biomarker Test Product and Service

    • 14.2 Becton Dickinson and Co

      • 14.2.1 Becton Dickinson and Co Company Details

      • 14.2.2 Becton Dickinson and Co Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Becton Dickinson and Co Tumor Biomarker Test Product and Service

    • 14.3 Agilent Technologies

      • 14.3.1 Agilent Technologies Company Details

      • 14.3.2 Agilent Technologies Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Agilent Technologies Tumor Biomarker Test Product and Service

    • 14.4 Abbott Laboratories, Inc

      • 14.4.1 Abbott Laboratories, Inc Company Details

      • 14.4.2 Abbott Laboratories, Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Abbott Laboratories, Inc Tumor Biomarker Test Product and Service

    • 14.5 Cancer Genetics Inc

      • 14.5.1 Cancer Genetics Inc Company Details

      • 14.5.2 Cancer Genetics Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Cancer Genetics Inc Tumor Biomarker Test Product and Service

    • 14.6 Foundation Medicine Inc

      • 14.6.1 Foundation Medicine Inc Company Details

      • 14.6.2 Foundation Medicine Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Foundation Medicine Inc Tumor Biomarker Test Product and Service

    • 14.7 Luminex Corporation

      • 14.7.1 Luminex Corporation Company Details

      • 14.7.2 Luminex Corporation Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Luminex Corporation Tumor Biomarker Test Product and Service

    • 14.8 Illumina Inc

      • 14.8.1 Illumina Inc Company Details

      • 14.8.2 Illumina Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Illumina Inc Tumor Biomarker Test Product and Service

    • 14.9 AstraZeneca

      • 14.9.1 AstraZeneca Company Details

      • 14.9.2 AstraZeneca Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 AstraZeneca Tumor Biomarker Test Product and Service

    • 14.10 LabCorp Of America Holdings

      • 14.10.1 LabCorp Of America Holdings Company Details

      • 14.10.2 LabCorp Of America Holdings Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 LabCorp Of America Holdings Tumor Biomarker Test Product and Service

    • 14.11 Biocept Inc

      • 14.11.1 Biocept Inc Company Details

      • 14.11.2 Biocept Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Biocept Inc Tumor Biomarker Test Product and Service

    • 14.12 NanoString Technologies Inc

      • 14.12.1 NanoString Technologies Inc Company Details

      • 14.12.2 NanoString Technologies Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 NanoString Technologies Inc Tumor Biomarker Test Product and Service

    • 14.13 Danaher Corporation

      • 14.13.1 Danaher Corporation Company Details

      • 14.13.2 Danaher Corporation Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Danaher Corporation Tumor Biomarker Test Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Tumor Biomarker Test

    • Figure Tumor Biomarker Test Picture

    • Table Global Tumor Biomarker Test Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Tumor Biomarker Test Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Tumor Biomarker Test Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Tumor Biomarker Test Consumption by Country (2017-2022)

    • Figure United States Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Table Europe Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure China Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Japan Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure India Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure South Korea Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Global Tumor Biomarker Test Consumption Forecast by Country (2022-2028)

    • Figure United States Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Specific Antigen Tests Consumption and Growth Rate (2017-2022)

    • Figure Global CTC Tests Consumption and Growth Rate (2017-2022)

    • Figure Global Alpha-Fetoprotein (AFP) Tests Consumption and Growth Rate (2017-2022)

    • Figure Global CA Test Consumption and Growth Rate (2017-2022)

    • Figure Global HER2 Tests Consumption and Growth Rate (2017-2022)

    • Figure Global BRCA Test Consumption and Growth Rate (2017-2022)

    • Figure Global Anaplastic Lymphoma Kinase (ALK) Tests Consumption and Growth Rate (2017-2022)

    • Figure Global EGFR Mutation Tests Consumption and Growth Rate (2017-2022)

    • Figure Global KRAS Test Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Colorectal Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Specific Antigen Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CTC Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alpha-Fetoprotein (AFP) Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CA Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global HER2 Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global BRCA Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anaplastic Lymphoma Kinase (ALK) Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global EGFR Mutation Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global KRAS Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Colorectal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Tumor Biomarker Test Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Tumor Biomarker Test Export by Region (Top 5 Countries) (2017-2028)

    • Table Myriad Genetics Inc (Foundation Year, Company Profile and etc.)

    • Table Myriad Genetics Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Myriad Genetics Inc Tumor Biomarker Test Product and Service

    • Table Becton Dickinson and Co (Foundation Year, Company Profile and etc.)

    • Table Becton Dickinson and Co Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Becton Dickinson and Co Tumor Biomarker Test Product and Service

    • Table Agilent Technologies (Foundation Year, Company Profile and etc.)

    • Table Agilent Technologies Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agilent Technologies Tumor Biomarker Test Product and Service

    • Table Abbott Laboratories, Inc (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories, Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories, Inc Tumor Biomarker Test Product and Service

    • Table Cancer Genetics Inc (Foundation Year, Company Profile and etc.)

    • Table Cancer Genetics Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cancer Genetics Inc Tumor Biomarker Test Product and Service

    • Table Foundation Medicine Inc (Foundation Year, Company Profile and etc.)

    • Table Foundation Medicine Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Foundation Medicine Inc Tumor Biomarker Test Product and Service

    • Table Luminex Corporation (Foundation Year, Company Profile and etc.)

    • Table Luminex Corporation Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Luminex Corporation Tumor Biomarker Test Product and Service

    • Table Illumina Inc (Foundation Year, Company Profile and etc.)

    • Table Illumina Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Illumina Inc Tumor Biomarker Test Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Tumor Biomarker Test Product and Service

    • Table LabCorp Of America Holdings (Foundation Year, Company Profile and etc.)

    • Table LabCorp Of America Holdings Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table LabCorp Of America Holdings Tumor Biomarker Test Product and Service

    • Table Biocept Inc (Foundation Year, Company Profile and etc.)

    • Table Biocept Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biocept Inc Tumor Biomarker Test Product and Service

    • Table NanoString Technologies Inc (Foundation Year, Company Profile and etc.)

    • Table NanoString Technologies Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table NanoString Technologies Inc Tumor Biomarker Test Product and Service

    • Table Danaher Corporation (Foundation Year, Company Profile and etc.)

    • Table Danaher Corporation Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Danaher Corporation Tumor Biomarker Test Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US